Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/3/2017
SIETES contiene 91704 citas

 
 
 1 a 20 de 987 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Chobanian AV. Hypertension in 2017- What is the right target?. JAMA 2017;317:579-80. [Ref.ID 101415]
2.Tiene citas relacionadas Cita con resumen
Kessler C, Ward MJ, McNaughton CD. Reducing adverse drug events: the need to rethink outpatient prescribing. JAMA 2016;316:2092-3. [Ref.ID 100974]
4. Cita con resumen
Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf 2016;25:1079-87. [Ref.ID 100658]
5.Tiene citas relacionadas Cita con resumen
Anónimo. Atrial fibrillation and stroke: unrecognised and undertreated. Lancet 2016;388:731. [Ref.ID 100608]
7. Cita con resumen
Anónimo. FDA grants experimental Huntington’s disease orphan drug status. DIA Daily 2016:1. [Ref.ID 100438]
8. Cita con resumen
Lee TC, McDonald EG, Bonnici A, Tamblyn R. Pattern of inpatient laxative use. Waste not, want not . JAMA Intern Med 2016;176:1216-7. [Ref.ID 100433]
9. Cita con resumen
Wong J, Motulsky A, Eguale T, Buckeridge DL, Abrahamowicz M, Tamblyn R. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. JAMA 2016;315:2230-2. [Ref.ID 100316]
11. Cita con resumen
Satizabal CL, Beiser AS, Chouraki V, Chêne G, Dufouil C, Seshadri S. Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med 2016;374:523-32. [Ref.ID 100130]
12.Enlace a cita original Cita con resumen
Pedrós C, Formiga F, Corbella X, Arnau JM. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features. Eur J Clin Pharmacol 2016;72:219-26. [Ref.ID 100101]
13. Cita con resumen
Boukhris T, Sheehy O, Mottron L, Bérard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatrics 2015:14 de diciembre. [Ref.ID 99758]
15.Enlace a cita original
Barrenberg E, Garbe E. Use of over-the counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol 2015;71:1389-96. [Ref.ID 99626]
17. Cita con resumen
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154-62. [Ref.ID 99342]
18. Cita con resumen
Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation The STROKESTOP study. Circulation 2015;131:2176-84. [Ref.ID 99252]
19.Enlace a cita original
Herr M, Robine J-M, Pinot J, Arvieu J-J, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality nia Franch sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015;24:637-46. [Ref.ID 99178]
20. Cita con resumen
Qureshi WT, O'Neal WT, Khodneva Y, Judd S, Safford MM, Muntner P, Soliman EZ. Association between opioid use and atrial fibrillation. The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. JAMA Intern Med 2015;175:junio. [Ref.ID 99002]
Seleccionar todas
 
 1 a 20 de 987 siguiente >>